CELLDEX
"CELLDEX" is a word mark owned by Celldex Therapeutics, Inc., filed at the USPTO on April 13, 2023. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since September 26, 2026
- Filed
- April 13, 2023
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 97887331
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns CELLDEX
The owner and representative on file with the office.
Owner
Celldex Therapeutics, Inc.
Hampton, United States
Representative
Matthew Hintz, Esq.
Lowenstein Sandler LLP
What the mark covers
The products and services CELLDEX is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 5 granted
- Sou extension 5 filed
- Sou teas extension received
- Notice of approval of extension request e-mailed
- Sou extension 4 granted
- Sou extension 4 filed
- Sou teas extension received
- Applicant/correspondence changes (non-responsive) entered
- Teas post publication amendment received
10 earlier steps on the official record.
About CELLDEX
Who owns the trademark "CELLDEX"?
The USPTO trademark "CELLDEX" (application 97887331) is owned by Celldex Therapeutics, Inc.
What is the status of "CELLDEX"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull CELLDEX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b97-7bfc-766f-948b-be02cd8360e2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b97-7bfc-766f-948b-be02cd8360e2",
"object": "trademark",
"mark_text": "CELLDEX",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "97887331",
"filing_date": "2023-04-13",
"nice_classes": [
5
],
"owners": [
{
"name": "CELLDEX THERAPEUTICS, INC.",
"entity_id": null
}
]
}